Health
CHIEF-HF: Heart Failure Symptoms Improved With Canagliflozin in Remote Trial – DocWire News
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly…
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly improve symptoms and quality of life in adults with heart failure, whether or not they also had type 2 diabetes. Findings from…
Continue Reading
-
Business24 hours agoThese ASX 200 shares could rise 50% to 60%
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland